Advertisement
Advertisement
TMCI
Treace Medical Concepts, Inc. Common Stock
1.26
USDSponsored
+0.01
+1.20%
Mar 25, 15:59 UTC -4
Closed
Pre-Market
1.28
+0.02
+1.98%
TMCI Earnings Reports
Positive Surprise Ratio
TMCI beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$46.66M
/-$0.29
Implied change from Q4 25 (Revenue/ EPS)
-25.36%
/+93.33%
Implied change from Q1 25 (Revenue/ EPS)
-11.24%
/+16.00%
Treace Medical Concepts, Inc. Common Stock earnings per share and revenue
On Feb 27, 2026, TMCI reported earnings of -0.15 USD per share (EPS) for Q4 25, beating the estimate of -0.15 USD, resulting in a 1.96% surprise. Revenue reached 62.52 million, compared to an expected 62.62 million, with a -0.16% difference. The market reacted with a -0.37% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.29 USD, with revenue projected to reach 46.66 million USD, implying an increase of 93.33% EPS, and decrease of -25.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.26
Surprise
-27.45%
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.21
Surprise
-65.56%
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.73%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
DarioHealth Corp. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$3.30
Actual
-$3.43
Surprise
-3.71%
Spectral AI, Inc. Class A Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.86%
SiNtx Technologies, Inc. Common Stock
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.56
Actual
-$0.56
Surprise
-1.60%
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.38
Surprise
-3.49%
FAQ
What were Treace Medical Concepts, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Treace Medical Concepts, Inc. Common Stock reported EPS of -$0.15, beating estimates by 1.96%, and revenue of $62.52M, -0.16% below expectations.
How did the market react to Treace Medical Concepts, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -0.37%, changed from $2.71 before the earnings release to $2.70 the day after.
When is Treace Medical Concepts, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Treace Medical Concepts, Inc. Common Stock's next earnings report?
Based on 8
analysts, Treace Medical Concepts, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of $46.66M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement